Testimonials

Background stories of how others approached and experienced their European Horizon funding trajectory.

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

image of Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

Published on | 1 year ago

Programmes Health

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.

Read the full article for details 
Other available testimonials

Testimonial

image of GLAUKOS - Circular Solution for the Textile Industry

GLAUKOS - Circular Solution for the Textile Industry

Bio Base Europe Pilot Plant coordinated the Glaukos project, which answered the call topic published in 2019 of Horizon 2020 Framework Programme ‘Develop bio-based fibres and/or functional molecules to improve the performance of textile products’ under the Framework of the Bio-based Industries Joint Undertaking (BBI JU). The consortium partners took up this challenge by valorising industrial side streams and setting up a circular approach to the textile industry.